MedPath

R. MANSTIEN (AUSTRALIA) LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

23

PPB:23

Drug Approvals

TELECEN 200 CAPSULES 200MG

Approval Date
Oct 2, 2024
PPB

LEVOCEN TABLETS 5MG

Approval Date
Apr 6, 2022
PPB

ALEACT 120 TABLETS 120MG

Approval Date
Jul 19, 2021
PPB

ALEACT 180 TABLETS 180MG

Approval Date
Jun 29, 2021
PPB

UFEXO 120 TABLETS 120MG

Approval Date
Mar 20, 2020
PPB

ZYTIZIN TABLETS 10MG

Approval Date
Mar 20, 2020
PPB

UFEXO 180 TABLETS 180MG

Approval Date
Mar 20, 2020
PPB

MEXIB 90 TABLETS 90MG

Approval Date
Nov 20, 2019
PPB

MEXIB 120 TABLETS 120MG

Approval Date
Nov 20, 2019
PPB

FAMOSIA TABLETS 40MG

Approval Date
Nov 20, 2019
PPB
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.